Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LsCR Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115109759A reveals engineered carbonyl reductases achieving 600g/g S/C ratio. Discover cost-effective biocatalytic routes for chiral alcohol production.
Novel LsCR mutant enables efficient synthesis of chiral alcohols for anticoagulants. Enhanced stability and activity reduce manufacturing costs for pharmaceutical intermediates.